ATE239444T1 - Inhibitoren der no-synthase - Google Patents

Inhibitoren der no-synthase

Info

Publication number
ATE239444T1
ATE239444T1 AT96904906T AT96904906T ATE239444T1 AT E239444 T1 ATE239444 T1 AT E239444T1 AT 96904906 T AT96904906 T AT 96904906T AT 96904906 T AT96904906 T AT 96904906T AT E239444 T1 ATE239444 T1 AT E239444T1
Authority
AT
Austria
Prior art keywords
cosmetic
pharmaceutical composition
disclosed
effective amount
composition
Prior art date
Application number
AT96904906T
Other languages
English (en)
Inventor
Paolo Giacomoni
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9476539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE239444(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE239444T1 publication Critical patent/ATE239444T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96904906T 1995-02-27 1996-02-26 Inhibitoren der no-synthase ATE239444T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9502267A FR2730930B1 (fr) 1995-02-27 1995-02-27 Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
PCT/FR1996/000296 WO1996026711A1 (fr) 1995-02-27 1996-02-26 Inhibiteurs de no-synthase

Publications (1)

Publication Number Publication Date
ATE239444T1 true ATE239444T1 (de) 2003-05-15

Family

ID=9476539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904906T ATE239444T1 (de) 1995-02-27 1996-02-26 Inhibitoren der no-synthase

Country Status (12)

Country Link
US (1) US7083799B1 (de)
EP (1) EP0812184B2 (de)
JP (1) JP2975431B2 (de)
AT (1) ATE239444T1 (de)
AU (1) AU4883096A (de)
CA (1) CA2212101A1 (de)
DE (1) DE69627988T3 (de)
ES (1) ES2198476T3 (de)
FI (1) FI115606B (de)
FR (1) FR2730930B1 (de)
NO (1) NO311067B1 (de)
WO (1) WO1996026711A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
US6214888B1 (en) 1996-09-18 2001-04-10 Applied Genetics Incorporated Dermatological compounds
WO1998036730A2 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die behandlung von rosacea
JP3699574B2 (ja) * 1997-10-30 2005-09-28 ホーユー株式会社 染毛料組成物
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
DE19962267A1 (de) * 1999-12-23 2001-06-28 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren NO-Synthasehemmern und einer oder mehreren Ascorbylverbindungen zur Stärkung der Barrierefunktion der Haut
DE10000840A1 (de) * 2000-01-12 2001-07-19 Beiersdorf Ag Verwendung eines oder mehrerer NO-Synthasehemmer
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
WO2002062306A1 (en) * 2001-01-25 2002-08-15 The General Hospital Corporation Nos inhibitors for treatment of wrinkles
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
DE10111054A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
DE10111052A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1716856A3 (de) * 2001-04-05 2009-02-18 Collagenex Pharmaceuticals, Inc. Die Behandlung von Akne
DE10153023A1 (de) * 2001-10-26 2003-05-15 Beiersdorf Ag Wirkstoffhaltige kosmetische Reinigungsemulsionen
MXPA04008684A (es) * 2002-03-12 2004-12-06 Galderma Res & Dev Uso de adapaleno para tratamiento de trastornos dermatologicos.
FR2837101B1 (fr) * 2002-03-12 2004-07-02 Galderma Res & Dev Utilisation de l'acide 6-[1-adamantyl)-4-methoxyphenyl]-2- naphthoique pour le traitement de desordres dermatologiques
US8192749B2 (en) * 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
EP1505961A4 (de) * 2002-05-20 2009-09-02 Collagenex Pharm Inc Verfahren zur behandlung allergischer reaktionen
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
DE10318526A1 (de) * 2003-04-24 2004-11-11 Beiersdorf Ag Reinigungsemulsion mit hohem Fettgehalt
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1684768A4 (de) * 2003-11-06 2007-06-06 Univ New York State Res Found Verfahren zur behandlung von ekzem
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
KR20220082095A (ko) 2015-10-30 2022-06-16 팀버 파마슈티칼스 엘엘씨 이소트레티노인 제형 및 이의 용도 및 사용 방법
WO2017139457A1 (en) * 2016-02-11 2017-08-17 Ohio University Compositions and methods for inhibiting uvb -irradiation damage by targeting constitutive nitric oxide synthases (cnos)
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2022153309A1 (en) * 2021-01-15 2022-07-21 Rich Psc Ltd. Topical composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096521A3 (de) * 1982-06-01 1985-01-23 THE PROCTER & GAMBLE COMPANY Enthaarungsmittel
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
FR2607498B1 (fr) * 1986-12-01 1991-04-05 Oreal Nouveaux salicylates lipophiles d'ammoniums quaternaires, leur utilisation en cosmetique et en dermopharmacie
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3836892A1 (de) * 1988-10-29 1990-05-03 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen
GB8929076D0 (en) 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5358969A (en) * 1991-12-16 1994-10-25 Washington University Method of inhibiting nitric oxide formation
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
AU1209995A (en) * 1993-11-17 1995-06-06 Duke University Medical Center Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
JP3583158B2 (ja) * 1994-03-01 2004-10-27 有限会社野々川商事 化粧料
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5476661A (en) * 1994-10-21 1995-12-19 Elizabeth Arden Co., Division Of Conopco, Inc. Compositions for topical application to skin, hair and nails
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5951990A (en) * 1995-05-15 1999-09-14 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions

Also Published As

Publication number Publication date
WO1996026711A1 (fr) 1996-09-06
FI973492L (fi) 1997-08-26
JP2975431B2 (ja) 1999-11-10
EP0812184B2 (de) 2009-02-18
NO311067B1 (no) 2001-10-08
FR2730930A1 (fr) 1996-08-30
EP0812184B1 (de) 2003-05-07
AU4883096A (en) 1996-09-18
JPH10503217A (ja) 1998-03-24
US7083799B1 (en) 2006-08-01
CA2212101A1 (fr) 1996-09-06
DE69627988T3 (de) 2009-09-10
ES2198476T3 (es) 2004-02-01
FI115606B (fi) 2005-06-15
NO973900D0 (no) 1997-08-25
FI973492A0 (fi) 1997-08-26
DE69627988T2 (de) 2004-01-22
NO973900L (no) 1997-10-27
DE69627988D1 (de) 2003-06-12
EP0812184A1 (de) 1997-12-17
FR2730930B1 (fr) 1997-04-04

Similar Documents

Publication Publication Date Title
DE69627988D1 (de) Inhibitoren der no-synthase
ATE137665T1 (de) Kosmetisches mittel
DE69636342D1 (de) Liponsäure in topischen mittel
AR005234A1 (es) Un tratamiento para la piel estructuralmente deteriorada y composicion cosmetica utilizada en el mismo
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
CO4130178A1 (es) Composicion para el cuidado personal en forma de gel, que tiene propiedades viscoelasticas
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
ATE180404T1 (de) Hemmung des haarwachstums
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
ATE247454T1 (de) Verwendung von wenigstens einem no-synthase hemmer zur behandlung empfindlicher haut
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
FI103950B1 (fi) Retinoidin kosmeettinen käyttö selluliitin hoitamiseksi
ES2151055T3 (es) Derivados de l-n6-(1-iminoetil)lisina utiles como inhibidores de oxido nitrico sintasa.
DE69508764D1 (de) Alkoholisches feuchtigkeitsspendendes after shave lotion
DE60106233D1 (de) Verwendung von ellagsäure zum schutz gegen verschmutzung
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BR9604011A (pt) Composição estável de aplicação tópica contendo o ácido ascórbico e pelo menos um poliol emulsão uso em uma composição de aplicação tópica contendo o ácido ascórbico uso da composição processo de tratamento cosmético
BR8502971A (pt) Composicoes cosmeticas que permitem retardar a aparicao do aspecto oleoso dos cabelos,utilizacao e processo para o tratamento dos cabelos
WO1998018440A3 (fr) Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles
BR0115389A (pt) Composição cosmética, método cosmético e uso de composição tópica
BR9502184A (pt) Composições cosmeticas de uso tópico utilização de composições processo de tratamento cosmético
ES2152558T3 (es) Derivados de l-n6-(1-iminoetil)lisina utiles como inhibidores de oxido nitrico sintasa.
WO1999013819A3 (en) Composition and method for reducing stinging in skin
ZA957506B (en) L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0812184

Country of ref document: EP

REN Ceased due to non-payment of the annual fee